Pulmonary embolism special scenario pregnancy

Revision as of 21:36, 12 July 2014 by Rim Halaby (talk | contribs) (/* 2012 VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (DO NOT EDIT){{cite journal| author=Bates S...)
Jump to navigation Jump to search


Resident
Survival
Guide

Pulmonary Embolism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary Embolism from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

Assessment of Clinical Probability and Risk Scores

Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores

History and Symptoms

Physical Examination

Laboratory Findings

Arterial Blood Gas Analysis

D-dimer

Biomarkers

Electrocardiogram

Chest X Ray

Ventilation/Perfusion Scan

Echocardiography

Compression Ultrasonography

CT

MRI

Treatment

Treatment approach

Medical Therapy

IVC Filter

Pulmonary Embolectomy

Pulmonary Thromboendarterectomy

Discharge Care and Long Term Treatment

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-Up

Support group

Special Scenario

Pregnancy

Cancer

Trials

Landmark Trials

Case Studies

Case #1

Pulmonary embolism special scenario pregnancy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary embolism special scenario pregnancy

CDC on Pulmonary embolism special scenario pregnancy

Pulmonary embolism special scenario pregnancy in the news

Blogs on Pulmonary embolism special scenario pregnancy

Directions to Hospitals Treating Pulmonary embolism special scenario pregnancy

Risk calculators and risk factors for Pulmonary embolism special scenario pregnancy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Special Scenario

Pregnancy

  • LMWH is the preferred treatment. (Grade 1C)
  • Warfarin is contraindicated.
    • Embryopathy is at increased risk at 6 - 12 weeks. (Grade 2C)
  • Continue anticoagulation for 6 weeks or more postpartum. (Grade 1C)
  • Heparin and warfarin are safe for nursing infants.

Cancer

  • The recurrence rate of pulmonary emboli is 30% after a year.
  • For treatment LMWH is recommended for the first 3 - 6 months.(Grade 1A)
  • Later, warfarin can be used after 3-6 months.
  • Anticoagulation should be continued.

References

Template:WH Template:WS